Search Results

• • 10 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Gene delivery to the hypoglossal motor system: preclinical studies and translational potential.

  Authors:Brendan M. Doyle, Michele L. Singer, Thomaz Fleury-Curado, Sabhya Rana, Ethan S. Benevides, Barry J. Byrne, et al.From:Gene Therapy (Vol. 28, Issue 7-8) Peer-Reviewed

  Aug. 20218,842 words Report 1460L

   Citation Only

• Correction: Targeted gene correction in the mdx mouse using short DNA fragments: towards application with bone marrow-derived cells for autologous remodeling of dystrophic muscle.

  Authors:R. M. Kapsa, A. F. Quigley, J. Vadolas, K. Steeper, P. A. Ioannou, E. Byrne, et al.From:Gene Therapy (Vol. 28, Issue 7-8) Peer-Reviewed

  Aug. 2021596 words Correction notice 1540L

   Citation Only

• MiR-140-5p inhibits oxidized low-density lipoprotein-induced oxidative stress and cell apoptosis via targeting toll-like receptor 4.

  Authors:Huifang Liu, Ziming Mao, Jing Zhu, Minyan Shen, and Fengling ChenFrom:Gene Therapy (Vol. 28, Issue 7-8) Peer-Reviewed

  Aug. 20214,653 words Report 1400L

   Citation Only

• Prime editing - an update on the field.

  Authors:Janine Scholefield and Patrick T. HarrisonFrom:Gene Therapy (Vol. 28, Issue 7-8) Peer-Reviewed

  Aug. 20213,821 words Article 1570L

   Citation Only

• Site-specific modifications to AAV8 capsid yields enhanced brain transduction in the neonatal MPS IIIB mouse.

  Authors:Janine A. Gilkes, Benjamin L. Judkins, Brontie N. Herrera, Ronald J. Mandel, Sanford L. Boye, Shannon E. Boye, et al.From:Gene Therapy (Vol. 28, Issue 7-8) Peer-Reviewed

  Aug. 20215,275 words Report 1480L

   Citation Only

• Gene therapy in the CNS--one size does not fit all.

  Author:Melissa R. AndrewsFrom:Gene Therapy (Vol. 28, Issue 7-8) Peer-Reviewed

  Aug. 20212,450 words Article 1600L

   Citation Only

• Transduction patterns in the CNS following various routes of AAV-5-mediated gene delivery.

  Authors:K. L. Pietersz, R. M. Martier, M. S. Baatje, J. M. Liefhebber, C. C. Brouwers, S. M. Pouw, et al.From:Gene Therapy (Vol. 28, Issue 7-8) Peer-Reviewed

  Aug. 20217,190 words Report 1390L

   Citation Only

• Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice.

  Authors:Tess Torregrosa, Sydney Lehman, Sam Hana, Galina Marsh, Shanqin Xu, Kathryn Koszka, et al.From:Gene Therapy (Vol. 28, Issue 7-8) Peer-Reviewed

  Aug. 20218,137 words Author abstract 1570L

   Citation Only

• AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo.

  Authors:Ling Yin, Geoffrey D. Keeler, Yuanhui Zhang, Brad E. Hoffman, Chen Ling, Keyun Qing, et al.From:Gene Therapy (Vol. 28, Issue 7-8) Peer-Reviewed

  Aug. 20217,228 words Report 1550L

   Citation Only

• Correction: Conditional replication of oncolytic viruses based on detection of oncogenic mRNA.

  Author:M. RentelnFrom:Gene Therapy (Vol. 28, Issue 7-8) Peer-Reviewed

  Aug. 2021244 words Correction notice, B... 1600L

   Citation Only